Navigation Links
A new contraceptive

A unique protein that only occurs in sperm could be the key to a new contraceptive for both the sexes.The protein, named CatSper, is an ion channel protein that controls the flow of calcium into sperm tails. Calcium is crucial in enabling sperm to swim, so a drug designed to block the channel would immobilise sperm and prevent fertilisation.

The discovery is reported by Dr David Clapham, from the Howard Hughes Medical Institute, and colleagues from Harvard Medical School."This is the only protein// I've ever seen that localises to only one tissue," said Dr Clapham. "We looked carefully through at least fifty human tissues, and the only place it turned up was in the testes."

"Futhermore, the only place it turned up within the testes was in sperm. And within sperm, it is found only in the principal piece of the tail." It is also specific to mature sperm and does not appear to be expressed in sperm precursor cells, or in immature sperm.The very specific role of the protein means that a contraceptive designed to disrupt it would have far fewer side effects than a hormone-based contraceptive. Hormones are found in many different tissues.

Working with mice, the researchers discovered that the sperm of mice without the CatSper gene were unable to penetrate the outer covering of the egg, the zona pellucida. But when the researchers mixed the sperm with eggs that had the covering removed, they fertilised normally.

A contraceptive designed to prevent fertilisation would not interfere with the gene but simply inhibit the ion channel protein, so that calcium could not pass through. "If a drug could be designed to block this ion channel specifically, it could be taken by men or women.It would not have to be taken for a very long period to block fertilisation, perhaps only just before or after intercourse", said Dr Chapman.


'"/>




Page: 1

Related medicine news :

1. Another injectable contraceptive Pill approved by FDA
2. Male contraceptive in trial
3. Hormone contraceptives lead to bone problems
4. A new male contraceptive
5. Spray on contraceptive clears Phase I trial
6. Indian Health Ministry approves sale of Emergency contraceptives as over the counter drug
7. Lower doses of oral contraceptives helpful in treating acne
8. Dermaseptins: Potent vaginal contraceptives
9. Oral contraceptives safe for women with Lupus erythematosus
10. Islamic Medical Ethics opposes Irreversible contraceptive and surrogate motherhood.
11. The conception of Anya, a period-free contraceptive pill
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/16/2017)... ... August 16, 2017 , ... Melbourne’s reign as the world’s most liveable ... Unit’s (EIU) annual Liveability Index. , The Index surveys 140 of the world’s cities ... 2006, Melbourne has consistently come in the top three of the index. So what ...
(Date:8/16/2017)... ... August 16, 2017 , ... Connexion Point, a technology-enabled healthcare services company ... fourth consecutive year. With 197% revenue growth over the past three years, ... growing companies. , Previous honors include ranking 86th on the Inc. 500 ...
(Date:8/16/2017)... Rochester, Michigan (PRWEB) , ... August 16, 2017 ... ... treatment options to patients suffering from chronic pelvic pain. In addition to ... various pelvic pain disorders including endometriosis, menorrhagia (abnormal heavy bleeding during menstruation), uterine ...
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... ... an annual all-encompassing awards program which recognizes organizations that demonstrate the core values ... of comprehensive award categories. , “As a global company, we are expanding our ...
(Date:8/16/2017)... ... ... “Mom, God's Got This: Jamie's Story” is the creation of published author, Karen F. Norton, ... insatiable appetite for God’s Word. , “I froze between the half walls, shelves on my ... oatmeal. I have one to this day on proud display in my dining room hutch; ...
Breaking Medicine News(10 mins):
(Date:8/1/2017)... CerSci Therapeutics , a non-opioid drug development firm based ... notice from the National Institute on Drug Abuse (NIDA) ... has been awarded a Direct-to-Phase II Small Business Innovation ... an additional $1,000,000 to follow in 2018. These funds ... lead non-opioid drug candidate CT-044 to the Food and ...
(Date:7/28/2017)... 2017 EnvoyHealth, a Diplomat company, has partnered with ... CleverCap LITE, a technology designed to improve patient medication ... health technology solutions and services that help track and ... CleverCap LITE offers medication monitoring and control for ... Records date and time ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals Company, ... our clinical trial evaluating Altemia TM , an oral ... and Sickle Cell Disease (SCD). The SCOT Trial, is ... efficacy and safety of Altemia TM in pediatric ... under US IND 125274. ...
Breaking Medicine Technology: